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INTRODUCTION
Pacemaker lead infection is a rare but a dangerous compli-
cation with a high mortality (1). The estimated incidence of
the infection after permanent endocardial pacemaker implan-
tation varies from 0.2% to 3% (2). Fungal infections of pace-
makers are particularly rare. Diagnosis of pacemaker lead
infection can be difficult; however, a recent report has suggest-
ed that the transesophageal echocardiography could be cru-
cial in diagnosis by visualizing pacing wire vegetation (3).
Several studies have reported that the medical treatment alone
was rarely successful, and thus infected leads should be re-
moved quickly for optimal management (4-6). In this article,
we report a case of Aspergillus infection in a large thrombus
on a pacemaker lead, whicht was well visualized on a two-
dimensional transesophageal echocardiography.
CASE REPORT
A 30-yr-old man with a chief complaint of exertional dys-
pnea for 3 months was admitted to our hospital. A DDDR
permanent pacemaker had been implanted 3 yr before due
to sick sinus syndrome with complete atrioventricular block.
After three months of pacemaker insertion, no visible P waves
nor A waves of transmitral or transtricuspid flow were observ-
ed on the electrocardiogram or Doppler echocardiogram, re-
spectively. An electrophysiologic study did not reveal any
electrical activity in either atria (so-called “atrial paralysis”).
Thus, the pacing mode had been changed to VVIR. He has
been well since that time.
On admission, the patient had no fever, but a systolic mur-
mur at the left lower sternal border and a mild hepatomegaly
were discovered on physical examination. Oxygen saturation
was 90% to 96% at room temperature. Peripheral blood ex-
amination revealed 18,500 white cells per cubic millimeter
with 43% eosinophils, and the total eosinophil count was
9,500 per cubic millimeter. Chest radiography film showed a
moderate cardiomegaly and increased pulmonary vascula-
ture. Transthoracic echocardiogram revealed a round mass
attached to the ventricular lead in the right atrium, which
extended across the tricuspid valve into the right ventricle
during systole, and a moderate to severe degree of tricuspid
regurgitation. Subsequently, transesophageal echocardiograph-
ic examination was performed with commercially available
5-MHz biplane transducer. A large round shaggy mass was
attached to the ventricular lead, moving in the right atrium
(Fig. 1). 
The lead was removed during cardiopulmonary bypass, and
a new epicardial pacing system was implanted. The function-
al ventricular pacemaker lead was encased in a large organized
thrombus (Fig. 2). However there was no thrombus on the
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Aspergillus Infection in a Large Thrombus of a Permanent Ventricular
Pacing Lead
Pacemaker lead infection is a rare but a dangerous complication. Diagnosis can
usually be established by the clinical picture and blood cultures. Transesophageal
two dimensional echocardiography might be crucial in the diagnosis by visualiz-
ing pacing lead vegetations. Medical treatment alone is rarely successful, and
several studies have suggested the infected pacemaker systems should be re-
moved quickly for optimal management. We describe a case of Aspergillus infec-
tion in a permanent ventricular pacing lead, which appears to be the first reported
case in Korea. A 30-yr-old man was evaluated for the symptoms and signs of con-
gestive heart failure 3 yr after DDD pacemaker implantation. The transthoracic
and transesophageal echocardiogram showed a large movable round shaggy
mass attached to a ventricular lead in the right atrium. The atrial and ventricular
leads were removed during cardiopulmonary bypass, and a new epicardial pacing
system was implanted. The functional ventricular pacemaker lead was encased in
a large organized thrombus. Histological findings were consistent with Aspergillus
infection in a large thrombus attached to a pacemaker lead. 
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atrial pacemaker lead. The histological examination showed
mycelial hyphae in the thrombus accompanied by a massive
infiltration of eosinophils (Fig. 3). This pathologic finding
was consistent with Aspergillus infection in the thrombus.
On the 2nd postoperative day, white cell count was 11,700
per cubic millimeter with 80% neutrophils, 20% lympho-
cytes, and 2% eosinophils, and the total eosinophil count
decreased to 234 per cubic millimeter. On the 7th postop-
erative day, there was a sudden onset of hemoptysis. High
resolution computed tomogram showed a consolidation with
inflammatory infiltration in the right upper lobe. Intravenous
amphotericin B was administered for 6 weeks (total dose
1,365 mg), and then the patient was discharged from the
hospital under afebrile condition. The patient was well dur-
Fig. 1. Transesophageal echocardiographic view demonstrating a large round mass in the right atrium (RA), encased to the ventricular
lead. A: longitudinal plane. B: horizontal plane. LA: left atrium.
A B
Fig. 2. The functional ventricular pacemaker lead is encased by
a large organized thrombotic material. However, there is no
thrombus on the atrial pacemaker lead (upper wire).
Fig. 3. A section of the right atrial thrombus reveals abundant




RAing the 3 yr of follow-up.
DISCUSSION
Implantation of a permanent transvenous pacemaker is a
procedure well accepted for the treatment of cardiac conduc-
tion disturbance and arrhythmias. Pacemaker endocarditis
is a less common but a severe complication that may threat-
en the patient’s life (7). Though uncommon, infection asso-
ciated with these permanently indwelling intravascular pros-
theses may occur with little local evidence of inflammation.
Incidence of pacemaker system infection is estimated between
0.2% and 3% according to the literature (2). The infection
process can affect any part of the pacemaker system, most
commonly the pocket site. Pacemaker endocarditis most often
arises from the infected pocket. But our patient had no evi-
dence of pocket infection. The possible cause of significant
eosinophila in our patient is probably allergic reaction to
Aspergillus infection. After removal of infected leads, the
peripheral blood eosinophil counts markedly decreased to
normal level.
Thrombi commonly form on the electrodes, and most of
them remain asymptomatic (8, 9). The high incidence of
thrombus formation is supported by the autopsy data (10).
The endothelization of an electrode causes a thickening of the
wire, which can be detected by the two-dimensional echocar-
diography (11). However, if this thickening is redundant, it
might be difficult to distinguish from a vegetation. Deposi-
tion of thrombi on the lead seeded by blood borne bacteria
is another, probably less common, possibility for developing
pacemaker endocarditis. In these cases, the source of infection
can rarely be identified (12, 13). 
Pacemaker-related fungal infection is extremely rare (14).
A case of disseminated aspergillosis and pacemaker endo-
carditis has been described in a 65-yr-old woman with fever
of unknown origin (16). The patient had no recognized risk
factors for the development of fungal infection. A functional
transvenous pacemaker lead was completely encased in a large
infected thrombus and might have been the initial site of in-
fection. However, most disseminated infection due to Asper-
gillus species has been reported only in patients with a com-
promised host defense system. Aspergillus endocarditis, on
the other hand, affects patients with prosthetic cardiac valves
who are not usually immunosuppressed (16). Infection could
arise in several ways: airborne organisms may settle into the
operative field during valve replacement; they may be intro-
duced when intravascular catheters are placed; or they may
enter the bloodstream from the lungs. In our patient, the
source of the infection is not known. But the causative factor
was a huge intracardiac thrombus formation due to blood
stasis from atrial paralysis. He had not received anticoagu-
lants after the implantation of the transvenous pacemaker.
It must be emphasized that the presence of blood stasis due
to significant tricuspid regurgitation or paralysis of the right
atrium, necessitates a long-term anticoagulant therapy and
serial echocardiogram. Moreover, Zager et al. (17) suggested
that the epicardial pacemaker electrodes be considered in pa-
tients at high risk of thrombosis. 
One of the major advantages of echocardiography is non-
invasive detection of a vegetation, a hallmark of the lead in-
fection. Transthoracic echocardiography (TTE) demonstrated
a vegetation in only 23% of patients, whereas transesophageal
echocardiography (TEE) disclosed an abnormal appearance
on the pacemaker lead in 94% (18). The major advantage of
TEE is related to its ability to demonstrate tricuspid involve-
ment, particularly in patients whose poor echogenecity ren-
dered TTE unreliable (19). The high rate of uncontrolled
infection or relapse among patients with septicemia in rela-
tion to pacemaker material infection rationalizes the need
for an immediate removal of the entire pacing system (18).
This is obvious for systemic infection related to lead contam-
ination and is also important in obvious infection of the sub-
cutaneous part of the lead. The choice of the technique of
ablation (surgical or subcutaneous) was based on the size of
the vegetation assessed on TEE, the presence of morpholog-
ical change of the tricuspid valve, and the general condition
of the patient. 
Because the diagnosis of fungal infection has usually to be
made premortem, recommendations for treatment of fungal
endocarditis must be based upon indirect observation. These
include the sensitivity of most fungi to amphotericin B, the
known failure of antimicrobial therapy alone to cure either
Aspergillus endocarditis or pacemaker infection (2), and the
success of surgical removal of bacterially infected pacemaker
systems (18). Therefore, the treatment of choice would be sur-
gical removal of infected pacemaker system and associated
vegetations combined with systemic administration of am-
photericin B (14).
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